Raia Drogasil SA RADL3

Morningstar Rating
BRL 25.38 −0.28 (1.09%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RADL3 is trading at a 61% premium.
Price
BRL 25.33
Fair Value
BRL 89.59
Uncertainty
Medium
1-Star Price
BRL 44.79
5-Star Price
BRL 66.84
Economic Moat
Lrqky
Capital Allocation

Trading Information

Previous Close Price
BRL 25.66
Day Range
BRL 25.1125.55
52-Week Range
BRL 24.3030.40
Bid/Ask
BRL 0.00 / BRL 0.00
Market Cap
BRL 43.53 Bil
Volume/Avg
6.3 Mil / 6.5 Mil

Key Statistics

Price/Earnings (Normalized)
36.68
Price/Sales
1.18
Dividend Yield (Trailing)
1.04%
Dividend Yield (Forward)
1.04%
Total Yield
1.04%

Company Profile

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Large Growth
Total Number of Employees
59,341

Comparables

Valuation

Metric
RADL3
HYPE3
PNVL3
Price/Earnings (Normalized)
36.689.8816.55
Price/Book Value
7.051.411.32
Price/Sales
1.182.140.33
Price/Cash Flow
21.3711.554.02
Price/Earnings
RADL3
HYPE3
PNVL3

Financial Strength

Metric
RADL3
HYPE3
PNVL3
Quick Ratio
0.461.390.69
Current Ratio
1.511.891.58
Interest Coverage
3.832.491.62
Quick Ratio
RADL3
HYPE3
PNVL3

Profitability

Metric
RADL3
HYPE3
PNVL3
Return on Assets (Normalized)
5.35%7.13%3.09%
Return on Equity (Normalized)
17.89%15.24%8.06%
Return on Invested Capital (Normalized)
11.06%11.20%6.85%
Return on Assets
RADL3
HYPE3
PNVL3

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Alibaba Health Information Technology Ltd
ALBHF
Zrgkzp$11.6 Bil
Alibaba Health Information Technology Ltd ADR
ALBBY
Bdgtx$11.6 Bil
Raia Drogasil SA ADR
RADLY
Tgfmj$7.9 Bil
Walgreens Boots Alliance Inc
WBA
TjlwxQpghk$7.5 Bil
Clicks Group Ltd ADR
CLCGY
Ddn$5.1 Bil
COSMOS Pharmaceutical Corp
CSMYF
Hcgqrv$4.0 Bil
Tsuruha Holdings Inc
TSUSF
Rrtcpk$3.1 Bil
Redcare Pharmacy NV ADR
SAEYY
Zylqmzy$3.0 Bil
DocMorris AG
ZRSEF
Hflk$475.7 Mil
High Tide Inc
HITI
Csjn$184.6 Mil

Sponsor Center